AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others
Executive Summary
AstraZeneca is expected to make a decision on whether to list an aaiPharma patent covering omeprazole in the "Orange Book" by the end of the month.
You may also be interested in...
Schwarz Omeprazole Launch Is Limited By Manufacturing Capacity
The limited manufacturing capacity of Schwarz' subsidiary Kremers Urban Development Co. means the company will supply generic omeprazole to all major pharmacy chains and drug wholesalers, but will distribute to mail order operations on a limited basis
Schwarz Omeprazole Launch Is Limited By Manufacturing Capacity
The limited manufacturing capacity of Schwarz' subsidiary Kremers Urban Development Co. means the company will supply generic omeprazole to all major pharmacy chains and drug wholesalers, but will distribute to mail order operations on a limited basis
FTC To Testify On Generic Reform; Agency Report May Be “Months” Away
Patent licensing deals that relate exclusively to listing in FDA's "Orange Book" will attract antitrust scrutiny, FTC Office of Policy Planning Director Ted Cruz said